REG - Avingtrans PLC - Exercise of Share Options & PDMR Share Dealing <Origin Href="QuoteRef">AVG.L</Origin>

AvingtransAnnouncement

13/12/2016 14:20

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20161212:nRSL6167Ra


RNS Number : 7435R
Avingtrans PLC
13 December 2016 
 
This announcement replaces the previous release made on 12 December 2016 at
4.30pm under RNS number 6167R. The previous announcement listed the wrong
admission date for the new ordinary shares, which has been corrected to 16
December 2016. All other information remains unchanged. 
 
Avingtrans Plc 
 
("Avingtrans" or the "Company" or the "Group") 
 
Exercise of Share Options & PDMR Share Dealing 
 
Avingtrans (AIM:AVG), a manufacturer of critical components and associated
services to the global aerospace, energy and medical sectors announces that on
12 December 2016 the Company issued 17,000 ordinary shares of 5 pence each
("Ordinary Shares") following the exercise of options under the Company's CSOP
share option scheme by Austen Adams, Managing Director of the Energy & Medical
Division and a PDMR of the Company, at an exercise price of 176p per share. 
 
The Company was subsequently notified that immediately following the issue, Mr
Adams onward sold the new Ordinary Shares at a price of 187p per share and as
a result, Mr Adams is not holding any Ordinary Shares in the capital of the
Company. 
 
Application has been made to the London Stock Exchange for the new Ordinary
Shares to be admitted to trading on AIM, with dealings expected to commence on
16 December 2016 ("Admission"). Upon Admission, the new Ordinary Shares will
rank pari passu in all respects with the existing Ordinary Shares of the
Company. 
 
After Admission, the Company's total issued share capital is 18,334,888
Ordinary Shares. Avingtrans does not hold any Ordinary Shares in treasury and
therefore following Admission, the total number of voting rights in Avingtrans
will be 18,334,888. 
 
The above figure 18,334,888 may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, Avingtrans under the
FSA's Disclosure Guidance and Transparency Rules. 
 
Enquiries: 
 
 Avingtrans plcSteve McQuillan, CEOStephen King, CFO  0135 469 2391  
 N+1 Singer Shaun DobsonLauren Kettle                 020 7496 3000  
 Newgate Threadneedle                                 020 7653 9850  
 (Financial PR)                                                      
 Adam Lloyd                                                          
 Ed   Treadwell                                                      
 
 
About Avingtrans 
 
                                                                                                                                                                         
 Avingtrans plc is engaged in the provision of highly engineered components, systems and services to the energy, medical and traffic management industries worldwide.    
 
 
                                                                                                                                                                                                                                                                   
   Energy and medical, engaged in the design and manufacture of safety critical equipment for the energy, medical, science and research communities, including oil and gas extraction and processing equipment, nuclear process plant, machined and fabricated     
   pressure and vacuum vessels and components. Also, design and manufacture of fabricated poles and cabinets for roadside safety cameras and rail track signalling. The strategy of the group, is to "buy and build" in regulated engineering niche markets, where 
   we can see potential consolidation opportunities, which can lead to significantly increased shareholder value over the medium to long term.                                                                                                                     
                                                                                                                                                                                                                                                                   
 
 
 1   Details of the person discharging managerial responsibilities / person closely associated                                                                                                          
 a)  Name                                                                                                                                                                                               Austen Adams                                         
 2   Reason for the notification                                                                                                                                                                        
 a)  Position/status                                                                                                                                                                                    Managing Director, Energy & Medical Division (PDMR)  
 b)  Initial notification /Amendment                                                                                                                                                                    Initial                                              
 3   Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor                                                                                      
 a)  Name                                                                                                                                                                                               Avingtrans plc                                       
 b)  LEI                                                                                                                                                                                                                                                     
 4   Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  
 a)  Description of the financial instrument, type of instrument  Identification code                                                                                                                   Ordinary Shares of 5p each GB0009188797              
 b)  Nature of the transaction                                                                                                                                                                          Exercise of options                                  
 c)  Price(s) and volume(s)                                                                                                                                                                             Price(s)  Volume(s) 176p  17,000                     
 d)  Aggregated information  - Aggregated volume  - Price                                                                                                                                               N/A (individual transaction)                         
 e)  Date of the transaction                                                                                                                                                                            12 November 2016                                     
 f)  Place of the transaction                                                                                                                                                                           Off-market transaction                               
 
 
Date of the transaction 
 
12 November 2016 
 
f) 
 
Place of the transaction 
 
Off-market transaction 
 
 1   Details of the person discharging managerial responsibilities / person closely associated                                                                                                          
 a)  Name                                                                                                                                                                                               Austen Adams                                         
 2   Reason for the notification                                                                                                                                                                        
 a)  Position/status                                                                                                                                                                                    Managing Director, Energy & Medical Division (PDMR)  
 b)  Initial notification /Amendment                                                                                                                                                                    Initial                                              
 3   Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor                                                                                      
 a)  Name                                                                                                                                                                                               Avingtrans plc                                       
 b)  LEI                                                                                                                                                                                                                                                     
 4   Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  
 a)  Description of the financial instrument, type of instrument  Identification code                                                                                                                   Ordinary Shares of 5p each GB0009188797              
 b)  Nature of the transaction                                                                                                                                                                          Sale of ordinary shares                              
 c)  Price(s) and volume(s)                                                                                                                                                                             Price(s)  Volume(s) 187p  17,000                     
 d)  Aggregated information  - Aggregated volume  - Price                                                                                                                                               N/A (individual transaction)                         
 e)  Date of the transaction                                                                                                                                                                            12 November 2016                                     
 f)  Place of the transaction                                                                                                                                                                           London Stock Exchange                                
 
 
Date of the transaction 
 
12 November 2016 
 
f) 
 
Place of the transaction 
 
London Stock Exchange 
 
This information is provided by RNS
The company news service from the London Stock Exchange